Skip to main content
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNO-ONCOLOGY
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MARYLAND, USA
SAN DIEGO, USA
PHILADELPHIA, USA
BRUSSELS, EU
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
ABOUT US
GET TO KNOW US
MEET THE TEAM
GALLERY
CONTACT US
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNO-ONCOLOGY
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MARYLAND, USA
SAN DIEGO, USA
PHILADELPHIA, USA
BRUSSELS, EU
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
ABOUT US
GET TO KNOW US
MEET THE TEAM
GALLERY
CONTACT US
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNO-ONCOLOGY
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MARYLAND, USA
SAN DIEGO, USA
PHILADELPHIA, USA
BRUSSELS, EU
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
IMMUNOTHERAPIES
OLIGONUCLEOTIDE THERAPEUTICS
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
ABOUT US
GET TO KNOW US
MEET THE TEAM
GALLERY
CONTACT US
Industry Experts
Loading
Kirby Morgan
Senior Biostatistician,
IDDI
Sessions
24-Jun-2024
15:35– 16:05
Salon C
Poster Presentation: New FDA Guidance on Data Monitoring Committees (DMCs) and Recommended Unblinded Data Reporting Practices for Effective Clinical Trial Oversight
LinkedIn
YouTube
Search
Search
Search
Username *
Password *
Login
